Zileuton

FDA Approved: * March 17, 2017
Pharm Company: * PACK PHARMS LLC
Category: Asthma

Zileuton (trade name Zyflo) is an orally active inhibitor of 5-lipoxygenase, and thus inhibits leukotrienes (LTB4, LTC4, LTD4, and LTE4) formation, used for the maintenance treatment of asthma. Zileuton was introduced in 1996 by Abbott Laboratories and is now marketed in two formulations by Cornerstone Therapeutics Inc. under the brand names Zyflo and Zyflo CR. The original immediate-release formulation, Zyflo, is taken four times per day. The extended-release formulation, Zyflo CR, is take... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Zileuton 600 mg Oral Tablet, Extended Release
NDC: 24486-902
Labeler:
Aristos Phamaceuticals, Inc.
Zileuton 600 mg Oral Tablet, Multilayer, Extended Release
NDC: 49884-723
Labeler:
Par Pharmaceutical, Inc.
Zileuton 600 mg Oral Tablet, Extended Release
NDC: 64980-206
Labeler:
Rising Pharmaceuticals, Inc.
Zileuton 600 mg Oral Tablet, Extended Release
NDC: 66993-485
Labeler:
Prasco, LLC
Zileuton 600 1/1 Oral Tablet, Extended Release
NDC: 68180-169
Labeler:
Lupin Pharmaceuticals, Inc.
Zileuton 600 mg Oral Tablet, Multilayer, Extended Release
NDC: 69339-130
Labeler:
Dash Pharmaceutical LLC

Related Brands

Drugs with the same active ingredients